In conclusion, BRCA1 (Pro871Leu), ERCC1 (Asn118Asn), CYP1B1 (Leu432Val), and SLCO1B3 (rs11045585) are associated with response to NCT in our cohort of breast cancer patients. This evidence concerns the gene CYP1B1 and breast carcinoma.